Clinomics Europe was established in Budapest in 2021 as the first EU subsidiary of Clinomics Inc., Korea. Our innovative, multiomics-based medical biotech company focuses on precision medicine and oncology. We develop novel molecular diagnostic tools based on cutting-edge technologies.